Al G. Dossetter

2017-11-09T11:43:43+00:00

Al G. Dossetter gained his Ph.D. from Nottingham University and after postdoctoral research at Harvard University joined AstraZeneca. He has 13 years of experience in medicinal chemistry spread across oncology (hormonal and kinase inhibitors), inflammation (OA and RA, enzyme inhibitors, and GPCR targets), and diabetes (obesity, GPCR, and enzyme inhibitors). In 2012, he cofounded MedChemica Limited to use matched molecular pair analysis to accelerate medicinal chemistry. Al is an enthusiastic advocate for science and is frequently invited to present his research.